Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 709-712

  Tani, Ryuzo ^a   Ozaki, Shuji ^a   Kosaka, Masaaki ^a   Fujiwara, Soichiro ^a   Shibata, Hironobu ^a   Wakatsuki, Shingo ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Apoptosis; Fas ligand; Liver; Natural killer cell Fas

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 6;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; LEUKEMIA; LIVER CELL DAMAGE; LIVER INJURY; MALE; NATURAL KILLER CELL; PHARYNGITIS; PRIORITY JOURNAL;

ADULT; APOPTOSIS; FAS LIGAND PROTEIN; FATAL OUTCOME; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LIVER DISEASES; MALE; MEMBRANE GLYCOPROTEINS; PHARYNGITIS;

EID: 0032846765     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01594.x     Document Type: Article

References (10)

1. Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yumura, K., Hara, J., Oda, K., Abe, K., Dohy, H., Inada, T., Kajihara, H. & Kuramoto, A. (1990) Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. British Journal of Haematology, 75, 49-59.
2. Kato, K., Ohshima, K., Ishihara, S., Anzai, K., Suzumiya, J. & Kikuchi, M. (1998) Elevated serum soluble Fas ligand in natural killer cell proliferative disorders. British Journal of Haematology, 103, 1164-1166.
3. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K.M., Krammer, P.H. & Moller, P. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Laboratory Investigation, 69, 415-429.
4. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
5. Perzova, R. & Loughran T.P., Jr (1997) Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. British Journal of Haematology, 97, 123-126.
6. Sato, K., Kimura, F., Nakamura, Y., Murakami, H., Yoshida, M., Tanaka, M., Nagata, S., Kanatani, Y., Wakimoto, N., Nagata, N. & Motoyoshi, K. (1996) An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. British Journal of Haematology, 94, 379-382.
7. Tanaka, M., Itai, T., Adachi, M. & Nagata, S. (1998) Downregulation of Fas ligand by shedding. Nature Medicine, 4, 31-36.
8. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. & Nagata, S. (1996) Fas ligand in human serum. Nature Medicine, 2, 317-322.
9. Tanaka, M., Suda, T., Yatomi, T., Nakamura, N. & Nagata, S. (1997) Lethal effect of recombinant human Fas ligand in mice pretreated with propionibacterium acnes. Journal of Immunology. 158, 2303-2309.
10. Yano, H., Fukuda, K., Haramaki, M., Momosaki, S., Ogasawara, S., Higaki, K. & Kojiro, M. (1996) Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. Journal of Hepatology, 25, 454-464.